Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Walgreens cuts stake in AmerisourceBergen through $1 billion share sale

Published 12/08/2022, 09:03 PM
Updated 12/08/2022, 10:20 PM
© Reuters. FILE PHOTO: People walk by a Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. REUTERS/Andrew Kelly/File Photo

(Reuters) -Walgreens Boots Alliance has sold some AmerisourceBergen (NYSE:ABC) Corp's shares for proceeds of $1 billion, the U.S. drugstore chain said on Thursday, further cutting its ownership in the drug distributor, by 3% to about 17%.

Walgreens, which will remain AmerisourceBergen' largest shareholder, said it would use the proceeds to pay down debt and to fund strategic priorities, including Walgreens-backed VillageMD's $9 billion acquisition of urgent care provider Summit Health.

Walgreens had earlier committed $3.5 billion, through an even mix of debt and equity, to support the deal, which was struck on Nov. 7.

A day later, Walgreens said it cut its stake in AmerisourceBergen (ABC) to about 20% from about 26% though a public offering of 10 million ABC shares.

The latest share sale includes $200 million that ABC will buy back from Walgreens under its share repurchase program, ABC said in a separate press release, adding these shares would be held in treasury.

The share sale has no impact on the long-term partnership between the two companies, Walgreens said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.